Moreover, there is a great diversity in the studied mutations in the APP, Tau and/or GS subunits [27], further limiting the applicability of the obtained results, rather than accounting for the vast majority of AD patients who suffer from sporadic AD [28,29]. The gene discussed is MAPT; the disease is Alzheimer disease.